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Background: The efficacy of stabilization appliance therapy for masticatory muscle
pain is debated. Therefore, there are currently no clear usage standards. We analyzed
patient factors influencing its efficacy and characterized masticatory muscle pain sub-
types to determine appropriate therapy candidates.
Methods: This case series study recruited patients diagnosed with local myalgia or
myofascial pain and used variables related to temporomandibular disorders in the
analysis. We used temporary appliance to screen patients for sleep bruxism for 2
weeks. Afterwards, we initiated therapy with stabilization appliances. Efficacy was
evaluated via tenderness intensity during muscle palpation and the treatment satis-
faction score after 2 months of treatment.
Results: We analyzed 62 (91%) patients. Tenderness upon muscle palpation was miti-
gated in 27 patients. Mitigated tenderness odds ratios were 0.035 for myofascial
pain, 0.804 for 15-item Patient Health Questionnaire scores, and 1.915 for facet
length. Thirty-nine patients expressed satisfaction; satisfaction odds ratios were
0.855 for 9-item Patient Health Questionnaire scores, 1.606 for facet length, and
4.023 for awake bruxism awareness.
Conclusions: Stabilization appliance therapy is most effective for patients with awake
bruxism awareness, local myalgia, long facets, and no psychosocial risk factors.
K E YWORD S
bruxism, myalgia, myalgia, myofacial pain, psychosocial factors, occlusal splints,
temporomandibular disorders
1 | INTRODUCTION
According to the U. S. National Institutes of Health, temporomandib-
ular disorder (TMD) is the second most common musculoskeletal
problem, after lower back pain, with a prevalence of approximately
5–12% in the United States (http://www.nidcr.nih.gov/
DataStatistics/FindDataByTopic/FacialPain). Approximately two
thirds of patients with TMD seek treatment, and approximately 15%
develop chronic TMD associated with an estimated annual cost of $4
billion in the United States.(Yap et al., 2003) Both joint and mastica-
tory muscle pain are associated with TMD, with masticatory muscle
pain occurring more frequently. In Asia, masticatory muscle pain is
present in 31.4% of TMD cases, making it the most common TMD
subtype.(Yap et al., 2003) Interestingly, another study(Fricton,
Kroening, Haley, & Siegert, 1985) found that in at least half of the
people with pain in the orofacial area, masticatory muscle pain was
the underlying condition. Thus, masticatory muscle pain a clinically
important problem.
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Stabilization appliance therapy (SAT) has long been used to treat
masticatory muscle pain,(Greene & Laskin, 1972) but its efficacy is
uncertain; some studies found that it is effective,(Alencar & Becker,
2009; Conti, dos Santos, Kogawa, de Castro Ferreira Conti, & de
Araujo Cdos, 2006; Ekberg, Vallon, & Nilner, 2003; Gavish, Winocur,
Ventura, Halachmi, & Gazit, 2002; Johansson, Wenneberg,
Wagersten, & Haraldson, 1991; Jokstad, Mo, & Krogstad, 2005;
Kreiner, Betancor, & Clark, 2001; Manns, Miralles, Santander, & Valdi-
via, 1983; Nilner et al., 2008; Rubinoff, Gross, & McCall, 1987) and
others concluded that it is not.(Dao, Lavigne, Charbonneau, Feine, &
Lund, 1994; Truelove, Huggins, Mancl, & Dworkin, 2006) The Japa-
nese Society for the Temporomandibular Joint only cautiously recom-
mends its use as the primary treatment for TMDs.(Yuasa et al., 2013)
This caution arises from factors including the inconsistencies between
TMD diagnostic criteria from different institutions, the lack of high-
quality research of SAT for masticatory muscle pain, and uncertainty
surrounding the causes of masticatory muscle pain.(Raphael et al.,
2012; Svensson & Graven-Nielsen, 2001; Yuasa et al., 2013) There-
fore, no clear standards for SAT for masticatory muscle pain exist. In
practice, however, SAT is widely used to treat masticatory muscle
pain, and some patients experience improvements. Nevertheless,
identifying patients who may benefit from SAT is an extremely diffi-
cult task. Hence, it is particularly necessary to identify the masticatory
muscle pain subtypes that can be effectively treated with SAT.
We analyzed patient factors that might influence the effective-
ness of SAT on masticatory muscle pain and aimed to identify the
masticatory muscle pain subtypes for which SAT is most appropriate.
2 | MATERIALS AND METHODS
2.1 | Patients
This case series study comprised 68 patients (14 men and 54 women;
mean age: 48.3 ± 14.4 years) out of 71 patients who presented with
orofacial pain at the Tokyo Dental College Suidobashi Hospital
between March and December 2016 and who were diagnosed with
local myalgia or myofascial pain. We did not recruit patients aged <18
years or those who had moderate or severe systemic disease (i.e.,
American Society of Anesthesiologists physical status class III or
above), loss of posterior support, or temporomandibular joint pain.
The exclusion criteria included failure to attend hospital appoint-
ments, a deteriorated condition necessitating a treatment switch, and
improvements before SAT was started. Written informed consent was
obtained from all the participants, and the study protocol was
approved by the Ethics Committee of Tokyo Dental College (Ethical
Clearance Number 670).
2.2 | Assessments
Items that are associated with TMD in the existing literature(Türp
& Schindler, 2012) were assessed and used in the analysis of
patient factors. During the first examination, we assessed tender-
ness upon muscle palpation. Tenderness intensity at the most ten-
der point during muscle palpation, used as an indicator of the pain
threshold, was evaluated on the visual analog scale (VAS). The
number of tender areas (both sides), pain-free mouth-opening
range, awareness of awake bruxism, presence of anterior guidance,
open bite, muscle fatigue on waking, torus palatinus or man-
dibularis, and tongue scalloping or lines on the inner surface of the
cheeks were also assessed. The bilateral muscle palpation area was
the anterior, middle, and posterior temporalis muscle and the ori-
gin, body, and insertion of the masseter muscle. Applying palpation
pressure involved using a weight of 1 kgf for 2 s, and prior to pal-
pation, finger pressure was calibrated using an algometer (adjust-
able spring coil with a small pin touching the examiner's hand
when the correct pressure is achieved) in order to standardize the
pressure.
To differentiate the types of myalgia, the duration of the pres-
sure was increased to 5 s. Myofascial pain was diagnosed if spread-
ing pain or referred pain was present, and local myalgia was
diagnosed if neither was present. Two doctors who have over 5
years of clinical experience in orofacial pain trained by the "Japanese
Orofacial Pain Society" made a diagnosis. The other patient factors
investigated comprised sleep duration, snoring or apnea, smoking,
daily alcohol consumption, daily caffeine consumption, duration of
computer usage time, and scores on three self-administered ques-
tionnaires. These questionnaires were the 9-item Patient Health
Questionnaire (PHQ-9), 15-item Patient Health Questionnaire (PHQ-
15), and 7-item Generalized Anxiety Disorder (GAD-7) scale. These
assessments screen for depression, somatization, and anxiety,
respectively.
2.3 | Temporary screening appliances
Temporary screen appliances were used to screen for facets formed
by sleeping. Facets formed by sleeping were observed on the sur-
face of the temporary screening appliances, and the length of the
facet was measured (Figure 1). Temporary screening appliances
F IGURE 1 Temporary screening appliances. Facets lengths
formed by the mandibular canines
2 NOGUCHI ET AL.NOGUCHI ET AL. 245
were made from autopolymerizing resin (Facet Resin, GC Corpora-
tion, Tokyo, Japan) for nighttime use. This resin was selected
because it combines sufficient strength with the appropriate degree
of readability for the formation of facets. The appliance's position
was adjusted by tapping it until it contacted all teeth equally with
canine guidance. After the adjustment was complete, an appliance
marker (Facet Resin Marker, GC Corporation) was applied to enable
easy observation of the appliance's surface texture. After 2 weeks,
the surface texture was assessed, and the lengths of the facets
formed by the mandibular canines were measured. However, it
should be noted that the effectiveness of temporary screening
appliance has not been reported in the past, and detection of brux-
ism by this is not certain.
2.4 | Stabilization appliances
After the screening appliance assessment, SAT was initiated. For each
patient, an appliance for nighttime use was made to cover the entire
maxillary dentition, and the stabilization appliance's position was
adjusted in the same manner as the screening appliance's position.(de
Leeuw & Klasser, 2013) The adjustment of the stabilization appliance
was performed by two dentists. The participants were asked to attend
fortnightly appointments at the hospital for stabilization appliance
adjustments.
2.5 | Potential differences between patients with
local myalgia and myofascial pain
From the obtained data, the background of patients with myalgia and
myofascial pain was investigated, and statistical analysis was
performed.
2.6 | Evaluating the efficacy of SAT
The efficacy of SAT was evaluated in terms of the VAS score indicat-
ing the intensity of tenderness during muscle palpation and the treat-
ment satisfaction score 2 months after the start of treatment. A VAS
score that was ≥30% lower after treatment than the score before
treatment was considered to indicate improvement, and any other
score was regarded as a lack of improvement. Treatment satisfaction
was self-assessed as (a) “greatly worsened”, (b) “worsened”, (c) “no
change”, (d) “improved”, or (e) “greatly improved”. A score of 1, 2, or 3
was indicated dissatisfaction whereas a score of 4 or 5 signified
satisfaction.
2.7 | Statistical analysis
SPSS version 24 (IBM, Armonk, NY, USA) was used for statistical anal-
ysis, and a p < .05 was considered statistically significant.
2.7.1 | Potential differences for the local myalgia
patients and the myofascial pain patients
We compared multiple baseline patient factors in patients with
local myalgia and myofascial pain. For the test of normality, the
Shapiro–Wilk test was used, and two groups were compared using
Mann–Whitney U-test, Student's t test, and χ2 tests. Logistic
regression analysis was performed on all items to obtain odds
ratios.
2.7.2 | Between-group comparisons of baseline
patient factors
We compared patients who exhibited improvements to those who did
not and those who expressed satisfaction to those who did not in
terms of multiple baseline patient factors. χ2 tests were used to com-
pare the following variables between the two pairs of groups: sex;
presence of myofascial pain, anterior guidance, open bite, awareness
of awake bruxism, muscle fatigue on waking, torus palatinus or man-
dibularis, tongue scalloping or lines on the inside of the cheeks, and
snoring or apnea; smoking; daily alcohol consumption; and daily caf-
feine consumption. The Mann–Whitney U-test was used to compare
the pretreatment baseline VAS score, number of tender areas, as well
as PHQ-9, PHQ-15, and GAD-7 scores. The Student's t test was used
to compare the baseline sleep duration, duration of computer and
smartphone use, pain-free mouth-opening range, and facet length in
the screening appliance's canine region. These variables were further
analyzed with logistic regression analysis to identify predictors associ-
ated with improvements in VAS scores and those associated with
satisfaction.
2.7.3 | Before and after stabilization appliance
therapy
Statistical analysis of changes in the number of tender areas, VAS
score (intensity of tenderness during muscle palpation), and pain-free
mouth opening range of myalgia at the time of initial examination of
all participants 1 and 2 months after starting SAT was performed by a
Friedman test.
2.7.4 | Between-group comparisons of patient
factors assessed before and after treatment
The Mann–Whitney U-test was used to compare the number of ten-
der areas 2 months after the start of treatment (between both pairs of
groups), VAS score at 2 months (between the satisfied and dissatisfied
patients), and treatment satisfaction score at 2 months (between the
patients who improved and those who did not). Finally, the Student's t
test was used to compare the pain-free mouth opening range at 2
months (between both pairs of groups).
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3 | RESULTS
First, this study design is uncoordinated and requires a lot of statistical
analysis, so there are Type I errors. Also note that the study power is
low due to the small sample sizes.
Of the 68 patients who consented to participate in the study, 3
were excluded because they failed to attend hospital appointments, 2
because their conditions deteriorated so markedly that they were
switched to different treatments, and 1 because of an improved con-
dition before SAT was initiated. Thus, the analysis was based on 62
patients (mean age: 48.3 ± 15.2 years). Of them, 12 were men (mean
age: 50.5 ±17.1 years) and 50 were women (mean age: 47.8 ± 14.7
years). Overall, there were significant improvements in the VAS score
(p < .001). There was no significant change in the number of tender
areas (p = .051) and the pain-free mouth opening range (p = .183;
Table 1).
3.1 | Potential differences between patients with
local myalgia and myofascial pain
There was a difference in the number of tender areas (p = 0.029), but
there was no difference in other items (Table 2). The odds ratio by
logistic regression analysis was 1.295 (Table 3).
3.2 | Improvement versus lack of improvement
Improvement was evident in 27 patients (10 men and 17 women;
mean age: 51.0 ±15.1 years) but not in the remaining 35 (2 men and
33 women; mean age: 46.3 ±15.2 years).
3.2.1 | Between-group comparisons of baseline
patient factors
The between-group comparisons, in terms of improvement versus
lack of improvement, are shown in Table 4. The improvement rate
was significantly higher for men than for women (p = .003). Compared
with those who did not experience improvements, those who did
were significantly less likely to have myofascial pain (p = .001), had
significantly lower PHQ-15 scores (p < .001), and had significantly lon-
ger facets (p = .006). Logistic regression analysis of these variables
showed that the odds ratios for improvement were 0.035 for
myofascial pain, 0.804 for PHQ-15 scores, and 1.915 for facet length.
Sex was not associated with a significant odds ratio (Table 5).
3.2.2 | Between-group comparisons of patient
factors assessed before and after treatment
Although there was no significant difference in the number of ten-
der areas on initial examination between patients who improved
and those who did not (p = .322) 2 months after the start of treat-
ment, the number was significantly lower among the patients who
had improved (p = .001). There was also no significant difference in
the pain-free mouth opening range on initial examination (p = .062),
but at 2 months, the range was significantly greater among the
patients who had improved (p = .019). Satisfaction levels were also
significantly higher among the patients who had improved (p
= .004).
3.3 | Satisfaction versus dissatisfaction
Satisfaction was expressed by 39 patients (9 men and 30 women;
mean age: 49.8 ±15.2 years), and dissatisfaction by 23 patients (3 men
and 20 women; mean age: 45.8 ±14.9 years).
3.3.1 | Between-group comparisons of baseline
patient factors
The between-group comparisons, in terms of satisfied versus dissatis-
fied patients, are shown in Table 4. Compared with the dissatisfied
patients, the satisfied patients were significantly more likely to be
aware of awake bruxism (p = .030), had significantly lower PHQ-9
scores (p = .041), and had significantly longer facets (p < .001). Logistic
regression analysis of these factors showed that the odds ratios for









Pain-free mouth opening range (mm)




Friedman test p = .183
VAS score (mm)




Friedman test p < .001*
Number of tender areas




Friedman test p = .051
Note. Statistical analysis of changes in number of tender areas, VAS score
and pain-free mouth opening range of myalgia at the time of initial
examination of all subjects, 1 month after starting SAT and 2 months after
SAT started, was performed by Friedman test.
Abbreviations: SAT, stabilization appliance therapy; VAS, visual analog
scale.
*p < .05.
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satisfaction were 0.855 for PHQ-9 scores, 1.606 for facet length, and
4.023 for awareness of awake bruxism (Table 5).
3.3.2 | Between-group comparisons of patient
factors assessed before and after treatment
Although there was no significant difference in VAS scores on initial
examination (p = .53) 2 months after the start of treatment, VAS
scores were significantly lower among satisfied patients than among
dissatisfied patients (p = .016). There was also no significant differ-
ence in the number of tender areas on initial examination (p = .542),
but at 2 months, the number among satisfied patients was signifi-
cantly lower (p = .016). There was no significant difference in the
pain-free mouth opening range at the initial examination (p = .529) or
at 2 months (p = .546).
4 | DISCUSSION
TMD is broadly divided into muscle pain and joint pain, with myal-
gia, tendonitis, myositis, and spasms categorized as muscle pain.
Under Diagnostic Criteria for TMDs classifications, myalgia is further
classified into local myalgia, myofascial pain with spreading pain, and
myofascial pain with referred pain. In this study, we divided myalgia
into local myalgia and myofascial pain with spreading or
referred pain.
TABLE 2 Potential differences between patients with local myalgia and myofascial pain
Variables Local myalgia Myofascial pain p value
Number of cases 48 14
Men/women 11/37 1/13
Age (year) 47 ± 16 50 ± 12
VAS score (pretreatment, mm) 63 ± 21 64 ± 25.2 0.52
Tender areas (pretreatment) 5.5 ± 2.3 7.3 ± 3.3 .03***
Pain-free mouth opening range (pretreatment, mm) 39.8 ± 8.9 39.6 ± 6.8 0.61
Anterior guidance (yes/no) 19/29 9/5 0.1
Open bite (yes/no) 19/29 3/11 0.21
Tooth grinding (during sleep, yes/no) 17/31 6/8 0.61
Awake bruxism (yes/no) 27/21 7/7 0.68
Jaw muscle fatigue (on waking, yes/no) 26/22 8/6 0.84
Torus palatinus (yes/no) 20/28 6/8 0.94
Torus mandibularis (yes/no) 29/19 7/7 0.48
Tongue scalloping (yes/no) 26/22 8/6 0.84
Cheek lines (yes/no) 31/17 6/8 0.14
Snoring or apnea (yes/no) 17/31 4/10 0.63
Smoking (yes/no) 5/43 2/12 0.69
Daily alcohol consumption (yes/no) 13/35 3/11 0.67
Daily caffeine consumption (yes/no) 25/23 10/4 0.2
Sleep duration (hr) 6.1 ± 1.1 6.3 ± 0.9 0.72
Computer usage (hr) 2.1 ± 2.4 1.4 ± 1.6 0.71
Smartphone usage (hr) 1.8 ± 1.8 2.0 ± 1.9 0.61
PHQ-9 score 8.2 ± 5.6 5.6 ± 4 0.15
PHQ-15 score 8.5 ± 5.5 12.2 ± 7.7 0.08
GAD-7 score 7.6 ± 4.7 5.9 ± 4.8 0.24
Facet length (mm) 4.4 ± 2.1 4.8 ± 2.1 0.58
Abbreviations: GAD-7, 7-item Generalized Anxiety Disorder scale; PHQ-9, 9-item Patient Health Questionnaire; PHQ-15, 15-item Patient Health
Questionnaire; VAS, visual analog scale.
*p < .05 with χ2 test.**p < .05 with Mann–Whitney U-test.
***p < .05 with Student's t test.
TABLE 3 Logistic regression analysis
Potential differences between patients with local myalgia and
myofascial pain
Odds ratio 95% CI p value
Tender areas 1.295 1.007–1.666 .044*
Smoking 1.088 0.980–1.208 0.114
*p < .05
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Muscle pain treatments can include patient education, cogni-
tive behavioral therapy, physiotherapy, SAT, and pharmacotherapy.
(Klasser, Greene, & Lavigne, 2010) Recently, the American Associa-
tion for Dental Research has strongly recommended that patients
with TMD should initially receive conservative, reversible, and
evidence-based treatments unless they exhibit contraindications
(http://www.hotetsu.com/s/doc/aadr2.pdf). Although appliance
therapy is regarded as comparatively noninvasive, its efficacy
remains unestablished, and it is debatable whether SAT and other
treatments that include physical intervention are appropriate.
Therefore, at present, the first choice of treatment for TMD is
conservative treatment such as self-massage, and the use of SAT is
not recommended. In this study, SAT helped improve myalgia as a
result, but we do not recommend SAT as the first choice.
However, it may be useful as an auxiliary option for myalgia
treatment.
Candidate selection for TMD must consider the distinction
between muscle and joint pain. Clinicians should also divide muscle
pain into local myalgia and myofascial pain and further investigate the
appropriate treatments for each. Adverse events and medical
expenses arising from inappropriate TMD treatment selections are
important issues. Therefore, detailed examinations of patient factors,
including psychosocial factors, are indispensable when selecting treat-
ments for masticatory muscle pain. Our results suggest that in addi-
tion to traditional TMD examinations, indicators for muscle pain
subtypes treatable with SAT include awareness of bruxism, appliance-
based bruxism subtype screenings, muscle pain subtype diagnoses,
and psychosocial factor screenings.












Number of cases 27 35 39 23
Men/women 10/17 2/33 0.003* 9/30 3/20 0.508
Age (year) 51 ± 15.1 46.3 ± 15.2 0.227 49.8 ± 15.2 45.8 ± 14.9 0.259
Local myalgia/myofascial pain 25/2 23/12 .001* 30/9 18/5 0.847
VAS score (pretreatment, mm) 61.7 ± 22.3 64.4 ± 20.9 0.515 64.4 ± 21.1 61.2 ± 22.3 0.529
Tender areas (pretreatment) 5.4 ± 2.2 6.3 ± 2.9 0.322 6.0 ± 2.8 5.9 ± 2.3 0.541
Pain-free mouth opening range
(pretreatment, mm)
41.4 ± 6.6 38.3 ± 9.3 0.1 39.6 ± 8.5 40.0 ± 8.3 0.545
Anterior guidance (yes/no) 11/16 16/19 0.695 20/19 7/16 0.182
Open bite (yes/no) 11/16 11/24 0.447 13/26 9/14 0.852
Tooth grinding (during sleep, yes/no) 11/16 12/23 0.601 16/23 7/16 0.574
Awake bruxism (yes/no) 17/10 17/18 0.259 26/13 8/15 0.03*
Jaw muscle fatigue (on waking,
yes/no)
15/12 19/16 0.921 23/16 11/12 0.394
Torus palatinus (yes/no) 10/17 10/25 0.48 13/26 7/16 0.964
Torus mandibularis (yes/no) 14/13 16/19 0.631 16/23 14/9 0.212
Tongue scalloping (yes/no) 12/15 22/13 0.149 20/19 14/9 0.639
Cheek lines (yes/no) 16/11 21/14 0.653 23/16 14/9 0.904
Snoring or apnea (yes/no) 9/18 12/23 0.848 14/25 7/16 0.574
Smoking (yes/no) 3/24 4/31 1 4/35 3/20 1
Daily alcohol consumption (yes/no) 10/17 6/29 0.138 11/28 5/18 0.794
Daily caffeine consumption (yes/no) 14/13 21/14 0.521 24/11 11/12 0.293
Sleep duration (hr) 6.3 ± 0.5 6 ± 1.3 0.485 6.4 ± 1.0 5.8 ± 1.0 0.867
Computer usage (hr) 2.6 ± 3.1 2.8 ± 3.3 0.538 2.7 ± 3.2 2.7 ± 3.3 0.547
Smartphone usage (hr) 1.4 ± 1.4 2.0 ± 1.9 0.361 1.8 ± 1.7 1.7 ± 1.8 0.512
PHQ-9 score 6.6 ± 4.7 8.4 ± 5.5 0.197 6.6 ± 4.1 9.8 ± 6.0 .041**
PHQ-15 score 6.1 ± 4.1 11.8 ± 6.4 <.001** 8.6 ± 5.9 10.5 ± 6.6 0.501
GAD-7 score 6.4 ± 4.2 7.8 ± 5.0 0.39 7.1 ± 4.6 7.4 ± 4.9 0.53
Facet length (mm) 5.3 ± 1.8 3.9 ± 2.0 .006*** 5.2 ± 1.9 3.4 ± 1.7 <.001***
Abbreviations: GAD-7, 7-item Generalized Anxiety Disorder scale; PHQ-9, 9-item Patient Health Questionnaire; PHQ-15, 15-item Patient Health
Questionnaire; VAS, visual analog scale.
*p < .05 with χ2 test.**p < .05 with Mann–Whitney U-test.
***p < .05 with Student's t test.
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SAT is a long-established treatment that is regarded as excellent
by some clinical practitioners. However, some studies have suggested
that the benefits of SAT do not surpass those of placebos and only
offers short-term relief for muscle pain.(Klasser et al., 2010) However,
our results show that the VAS scores of all participants decreased sig-
nificantly. This result suggests that SAT contributed to an increase in
the pain threshold and there may be an effect of pain relief in mastica-
tory muscles.
Because TMD arises from complex interactions between various
factors, the diagnostic criteria for control group patients with TMD
should ideally be like those for treatment group patients regarding
Diagnostic Criteria for TMDs Axes I and II (https://ubwp.buffalo.edu/
rdc-tmdinternational/tmd-assessmentdiagnosis/dc-tmd/). However,
ensuring such consistency is extremely difficult. Therefore, this study
did not include a control group. Instead, we categorized patients
based on whether the treatment ameliorated their symptoms and
then analyzed differences in patient factors between those categories.
Hence, a limitation of this study is that we did not investigate placebo
effects. Furthermore, the patients might have spontaneously healed,
so our evaluation of therapeutic efficacy might have included placebo
effects and spontaneous healing.
4.1 | Awareness of awake bruxism
Self-reported awake and sleep bruxism are both risk factors for TMD.
(Huhtela et al., 2016) Awake bruxism includes both tooth clenching
and light tooth contact. Habitual tooth contact is evident in 52.4% of
patients with TMD and is associated with a 1.944-fold increased
probability of continuance or worsening of TMD pain.(Sato et al.,
2006) Self-reported tooth contact or tooth clenching is also a risk fac-
tor for facial pain.(Glaros & Williams, 2012) In this study, 54.8% of the
participants were aware of having awake bruxism. Our finding that
awareness of awake bruxism was significantly more common among
satisfied patients than among dissatisfied patients was unexpected,
given that the stabilization appliances were only worn at night.
Because many of the highly satisfied patients were aware of having
awake bruxism and showed long facets in screening appliances, the
highly satisfied patients might have had both awake and sleep brux-
ism. Reissmann et al.(Reissmann et al., 2017) reported that patients
who were aware of having both awake and sleep bruxism were at an
increased risk of developing painful TMD. If the stabilization appliance
positively influenced sleep bruxism perhaps by relieving muscle
fatigue and physiological stress caused by grinding, patients may have
been highly satisfied due to a reduced risk of painful TMD. Because
we did not investigate biological responses during sleep, further
research is needed to test this hypothesis.
4.2 | Types of sleep bruxism
Sleep bruxism may cause muscle pain, and the use of stabilization
appliances to control sleep bruxism has been widely reported.(Klasser
et al., 2010) Recently, however, many authors have questioned
whether sleep bruxism causes muscle pain because several studies
comparing patients with masticatory muscle pain to a control group
found that muscle activity during sleep was actually greater in the
control group.(Lavigne, Rompré, Montplaisir, & Lobbezoo, 1997)
Moreover, other studies have shown that muscle activity decreases
when muscle pain is present.(Murray & Peck, 2007) These findings
have also cast doubt on the efficacy of SAT.(Svensson & Graven-Niel-
sen, 2001) However, no previous studies have assessed the efficacy
of SAT after classifying patients with muscle pain according to sleep
bruxism subtypes, so further research is required.
Polysomnography is the standard technique for analyzing sleep
bruxism, but it is expensive, requires specialist expertise for analysis
and diagnosis, and poses difficulties for patients due to the long
period of restraint required and the altered sleep environment. There-
fore, we used screening appliances in this study. Although screening
appliances do not provide extensive information, they suffice for sleep
bruxism screening and, compared with polysomnography, are less bur-
densome for patients. As the number and timing of events associated
with sleep bruxism vary from day to day, another advantage of using
screening appliances is that the results reflect the entire period of use.
We found that the patients with improved VAS scores and those
who were satisfied had significantly longer facets than those with no
improvement and those who were dissatisfied, respectively. Screening
appliance examinations may be important tests for whether patients
have muscle pain subtypes for which SAT may be effective. Long
facets are associated with grinding-type bruxism. During tooth grind-
ing, tooth engagement imposes excessive loads on the muscle, but the
stabilization appliances counteract the effects of tooth engagement
by reducing lateral pressure and mitigating negative effects on the
musculature. In a comparative study of patients with different types
of sleep bruxism, Yoshimi et al.(Yoshimi, Sasaguri, Tamaki, & Sato,
TABLE 5 Logistic regression analysis
OR 95% CI p value




PHQ-15 score 0.804 0.683–0.945 .008*
Facet length 1.915 1.199–3.058 .007*
Likelihood of obtaining satisfaction
Awake bruxism 4.023 1.063–15.223 .04*
PHQ-9 score 0.855 0.752–0.972 .016*
Facet length 1.606 1.126–2.291 .009*
Note. Logistic regression analysis was performed on items with significant
between-group differences. We treated sex, muscle pain type, and awake
bruxism as dummy variables. Others were treated as continuous variables.
Abbreviations: CI, confidence interval; OR, odds ratio; PHQ-9, 9-item
Patient Health Questionnaire; PHQ-15, 15-item Patient Health
Questionnaire.
*p < .05.
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2009) found that muscle activity was most intense during grinding.
This suggests that decreasing the force imposed during grinding
relieves muscle fatigue, which might have influenced the VAS
improvements and treatment satisfaction scores that we observed.
Furthermore, myalgia is believed to be caused by impaired blood flow
due to excessive muscle use and sympathetic reflexes.(de Leeuw &
Klasser, 2013) Although muscle stress reduction and psychological
stress may lead to blood flow improvements and positive health out-
comes by promoting bruxism by stabilization appliances, research is
needed that include a heart rate variability analysis, near-infrared
spectroscopy, electromyography, and accelerometer use.
4.3 | Type of muscle pain
Patients who had significantly improved VAS scores showed more
local myalgia than myofascial pain. Myofascial pain is characterized by
deep or spreading pain and is associated with factors such as impaired
peripheral blood flow (i.e., hypoxia), the pain-inducing action of
growth factors, and hypersensitivity of the sympathetic nervous sys-
tem that can increase sensitivity to palpation or tenderness to pres-
sure, sometimes with referred pain.(Maekawa, Clark, & Kuboki, 2002)
In other words, central sensitization or peripheral sensitization may be
involved. The difference in the tender areas between local myalgia
and myofascial pain in this study result also suggests that sensitization
is involved.
TMD is categorized as a type of functional somatic syndrome,
alongside fibromyalgia and somatic symptom disorder,(Henningsen,
Zipfel, & Herzog, 2007) and the diagnostic criteria for myofascial pain
and fibromyalgia have many similarities.(Wolfe et al., 1990) If TMD-
associated myofascial pain is truly like fibromyalgia, then SAT may be
less effective for myofascial pain than for local myalgia, as shown in
our results. If local myalgia is caused simply by muscle fatigue, then
SAT should be more effective for local myalgia than for myofascial
pain. However, the existence of psychosocial risk factors and the
involvement of central hyperalgesia, such as that observed in fibromy-
algia, must be considered when managing myofascial pain.
4.4 | Psychosocial risk factors
Psychosocial factors influence the risk of developing chronic lower
back pain and other musculoskeletal disorders,(Hasenbring, Hallner, &
Klasen, 2001) including chronic TMD.(Harper, Schrepf, & Clauw,
2016; Slade et al., 2016) We found that high PHQ-9 scores were sig-
nificantly associated with dissatisfaction with treatment and that high
PHQ-15 scores were associated with VAS scores indicating a lack of
improvement.
Depression is thought to be closely association with pain.(Wright
et al., 2004) Chronic stress due to factors such as pain causes both
depression and hyperalgesia,(Rivat et al., 2010) and depression impairs
the function of the descending pain modulatory system.(Stahl, 2002)
Screening for depression is regarded as essential in managing chronic
lower back pain,(Tsuji, Matsudaira, Sato, & Vietri, 2016) and accumu-
lating evidence indicates an association between musculoskeletal pain
and depression. For example, patients with TMD due to muscle pain
have higher depression scores than patients with other TMD sub-
types, suggesting that depression screenings would facilitate pain
management for patients with TMD.(Bertoli & de Leeuw, 2016)
The PHQ-9 is widely used in Japan as a screening tool, and its
use has highlighted the association between pain and depression.
High PHQ-9 scores are significantly associated with higher pain inten-
sities in patients with chronic lower back pain,(Vietri, Otsubo, Mont-
gomery, Tsuji, & Harada, 2015) and 22% of individuals who have been
injured for ≥90 days have PHQ-9 scores indicative of
depression,(Zhou & Jia, 2016) signifying that managing pain in
patients with high PHQ-9 scores is difficult. Such patients therefore
require the early adoption of a multifaceted approach, as satisfaction
is unlikely to be obtained with SAT alone.
Studies on psychosocial stress and TMD have shown that pro-
nounced somatic symptoms represent a strong risk factor for develop-
ing TMD.(Fillingim et al., 2013) The PHQ-15 is also effective for
evaluating fibromyalgia severities.(Häuser, Brähler, Wolfe, &
Henningsen, 2014) Fibromyalgia and TMD are both forms of func-
tional somatic syndrome,(Henningsen et al., 2007) and because they
have many similarities, the PHQ-15 can also be useful for assessing
patients with TMD. Fibromyalgia pain is thought to be neuropathic or
central pain rather than nociceptive pain, with pain hypersensitivity as
a contributing factor. High degrees of sensitivity to pressure, heat,
and pinprick stimulation have also been reported in chronic TMD;
(Greenspan et al., 2011; Greenspan et al., 2013) also, central
hyperalgesia is thought to be involved. We found that compared with
patients whose VAS scores indicated improvements, those whose
VAS scores indicated no improvement (i.e., patients with low pain
thresholds) had significantly higher PHQ-15 scores and a higher fre-
quency of myofascial pain. The contribution of somatic symptoms and
hyperalgesia must be considered when managing myofascial pain in
patients with high PHQ-15 scores because in this study, these
patients were less likely to experience improvements compared with
patients with myofascial pain who had low PHQ-15 scores. These
patients may need an alternative approach to SAT.
The GAD-7 is a valuable anxiety screening tool.(Löwe et al., 2008)
Although its use may be regarded as essential in managing TMD, we
found no significant difference in GAD-7 scores between the patients
who improved and those who did not or between the satisfied and
dissatisfied patients.
Our results showed that higher PHQ-9 scores were associated
with lower likelihoods of satisfaction with SAT, whereas higher PHQ-
15 scores were associated with lower likelihoods of experiencing
improvements, as reflected in VAS scores. In a study of patients with
residual pain following knee surgery, Bierke et al.(Bierke, Häner, &
Petersen, 2016) found that scoring ≥10 on both the PHQ-9 and PHQ-
15 was associated with significantly greater knee pain and a higher
likelihood of being dissatisfied with treatment, which is consistent
with our findings. Our findings are also consistent with those of other
studies that found that various psychosocial risk factors heightened
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sensitivity to pain and reduced the probability of patients responding
to standard treatments.(Ohrbach & Dworkin, 1998)
In TMD management, it is important to evaluate psychosocial risk
factors during both the initial examination and the course of treat-
ment and to consider approaches other than conventional treatments
such as conservative therapy, SAT, and physiotherapy.
5 | CONCLUSION
Various masticatory muscle pain subtypes exist. Therefore, detailed
examinations of factors, including psychosocial factors, are essential
for effectively treating patients with masticatory muscle pain.
Our results suggest that patients aware of awake bruxism and
with local myalgia who formed long facets on their stabilization appli-
ances would respond better to SAT than those who have myofascial
pain or formed short facets. High PHQ-9 scores indicate a reduced
likelihood of satisfaction with SAT, and high PHQ-15 scores indicate a
reduced likelihood of benefiting from this treatment in terms of VAS
scores for tenderness during muscle palpation. Therefore, SAT may be
most effective for patients aware of awake bruxism and with local
myalgia who form long facets on the stabilization appliances and who
lack psychosocial risk factors.
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